Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Continuous processing optimization with smarter tools
Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Changing Column Packing from an Art into a Science
View All Featured ArticlesHeadline News
Johnson & Johnson to acquire Ollin Biosciences for $2.2bn to expand ophthalmology pipeline
Abbott begins VOYAGER trial of investigational Encantor TAVI system
FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Best Practices of Downstream Protein Purification and Product Concentration
Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics, Sofie Östemar, Product Manager for Connected & Continuous Downstream Processing and Henrik Ihre, Ph.D. Director Strategic Technologies at Cytiva and Nigel Jackson Principal Engineer, Bioprocessing R&D at Pall Corporation
12th October 2022
Single-Use Chromatography – a Feasible Unit Operation?
Presented by Dr. Joachim Walter & Dr. Günter Jagschies
02nd July 2015
Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing
Presented by Clive Glover, PhD, Senior Marketing Manager, Cell & Gene Therapy at Pall and Rachel Legmann, PhD, Senior Manager, Process Development Services at Pall
13th November 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Amsphere TM A3
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















